Perosphere Technologies Inc. (Perosphere), a medical technology company developing next-generation coagulation diagnostics, today announced a Late-Breaking Science Poster Presentation at the ...
Findings from DEVOTE support clinical benefits of the high-dose regimen of nusinersen (50 mg and 28 mg) in both ...
Winter storms and seasonal illnesses have caused a critical need for blood donations, which hospitals rely on to treat their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results